Future Oncology (ISSN 1744-8301, 1479-6694) is a journal published by Taylor & Francis in the United Kingdom. It covers Biochemistry, Genetics and Molecular Biology, Medicine and Medicine (miscellaneous). It is indexed in Scopus, Web of Science, PubMed and HEC. Recorded metrics: impact factor 3.1, Scopus Q2, Web of Science Q2, CiteScore 4.9 and HEC W-Category. Article processing charge: USD 3,095.53. This profile brings together the journal's ISSN, publisher, country, subject area, HEC category, Scopus data, SJR and SCImago rank, Web of Science data, impact factor, indexing, open access status, APC, aims and scope, about the journal, author instructions, journal website and registration details from the most reputable indexes, in one place.
Future Oncology
Record last updated . Check current status at HEC HJRS, Scopus and the Web of Science Master Journal List before submitting. About our data.
Journal lists: Q2 journals · HEC W category journals · Scopus journals · Web of Science journals · PubMed journals · SCImago journals · SCIE journals · Impact factor journals · Q2 Biochemistry journals · Q2 Genetics and Molecular Biology journals
Quick answers about Future Oncology
Is Future Oncology HEC recognised?
Yes. The catalogue records Future Oncology in HEC category W of the HEC Journal Recognition System, where W is the highest and Y the lowest category. Confirm the current category on HEC's HJRS website before you submit.
Is Future Oncology indexed in Scopus?
Yes. Future Oncology is listed as Scopus-indexed, in quartile Q2, with a CiteScore of 4.9. Check its current status on the Scopus Sources page.
Is Future Oncology in Web of Science?
Yes. Future Oncology is listed as a Web of Science journal in the Science Citation Index Expanded (SCIE), with Web of Science quartile Q2. Confirm on Clarivate's Master Journal List.
What is the impact factor of Future Oncology?
The recorded journal impact factor of Future Oncology is 3.1. Clarivate updates impact factors every year in Journal Citation Reports.
Is Future Oncology open access, and what does it charge?
Future Oncology is not recorded as fully open access and its APC is USD 3,095.53. Fees change, so check the journal's website before you submit.
Who publishes Future Oncology?
Future Oncology is published by Taylor & Francis in United Kingdom, under ISSN 1744-8301 and 1479-6694.
Research profile
- 5,718articles indexed
- 110,069citations
- 120h-index
- 3.182-year mean citedness
- 2005first year indexed
Main research topics: Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Breast Cancer Treatment Studies, Lung Cancer Diagnosis and Treatment, Colorectal Cancer Treatments and Studies, Lung Cancer Research Studies.
Source: OpenAlex (CC0), retrieved 20 November 2026. Counts cover works OpenAlex has indexed and differ from Scopus and Web of Science.
Browse similar journals
- Biochemistry journals (2,272)
- Genetics and Molecular Biology journals (2,274)
- Medicine journals (8,023)
- Journals indexed in Scopus (31,185)
- Journals indexed in Web of Science (22,643)
- Journals indexed in PubMed (16,086)
- Journals indexed in HEC (34,823)
- Scopus Q2 journals (8,223)
- Web of Science Q2 journals (5,019)
- HEC W-Category journals (13,616)
- Journals published in the United Kingdom (7,333)
- Taylor & Francis journals (2,448)